Form 13-F position report

ELEVANCE HEALTH INC FORMERLY

Reported by Newport Trust Co

ELV CUSIP 036752103 Manager CIK 0001722329

Reported 927,194 shares, down 27,721 (2.9%) from the prior quarter.

Reported value -2.4%; share count -2.9% vs. the prior quarter.

Reduced
% of reported 13F value 0.97% This manager · Q3 2026
Shares 927,194 Quarter-end amount reported
Reported value $360,511,571 Fair value at quarter end
Consecutive quarters held 24 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 628684000
2022-03-31 659614000
2022-06-30 639933000
2022-09-30 593396000
2022-12-31 661864672
2023-03-31 588513118
2023-06-30 560978326
2023-09-30 540634018
2023-12-31 570832340
2024-03-31 611449923
2024-06-30 620845848
2024-09-30 586771120
2024-12-31 408045086
2025-03-31 464131897
2025-06-30 406869274
2025-09-30 330880373
2025-12-31 352309761
2026-03-31 288413787
2026-06-30 369294278
2026-09-30 360511571

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for ELEVANCE HEALTH INC FORMERLY held by Newport Trust Co.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 927,194 -27,721 (-2.9%) 0.97% $360,511,571 2026-11-12
Q2 2026 Reduced 954,915 -30,273 (-3.1%) 0.89% $369,294,278 2026-08-13
Q1 2026 Reduced 985,188 -19,832 (-2.0%) 0.71% $288,413,787 2026-05-14
Q4 2025 Reduced 1,005,020 -18,997 (-1.9%) 0.84% $352,309,761 2026-02-06
Q3 2025 Reduced 1,024,017 -22,027 (-2.1%) 0.75% $330,880,373 2025-10-31
Q2 2025 Reduced 1,046,044 -21,024 (-2.0%) 0.98% $406,869,274 2025-08-14
Q1 2025 Reduced 1,067,068 -39,045 (-3.5%) 1.19% $464,131,897 2025-05-14
Q4 2024 Reduced 1,106,113 -22,293 (-2.0%) 0.99% $408,045,086 2025-02-13
Q3 2024 Reduced 1,128,406 -17,362 (-1.5%) 1.42% $586,771,120 2024-11-14
Q2 2024 Reduced 1,145,768 -33,408 (-2.8%) 1.56% $620,845,848 2024-08-13
Q1 2024 Reduced 1,179,176 -31,343 (-2.6%) 1.66% $611,449,923 2024-05-15
Q4 2023 Reduced 1,210,519 -31,119 (-2.5%) 1.52% $570,832,340 2024-02-09
Q3 2023 Reduced 1,241,638 -21,002 (-1.7%) 1.66% $540,634,018 2023-11-08
Q2 2023 Reduced 1,262,640 -17,265 (-1.3%) 1.64% $560,978,326 2023-08-09
Q1 2023 Reduced 1,279,905 -10,355 (-0.8%) 1.63% $588,513,118 2023-05-09
Q4 2022 Reduced 1,290,260 -16,089 (-1.2%) 1.84% $661,864,672 2023-02-03
Q3 2022 Reduced 1,306,349 -19,717 (-1.5%) 2.01% $593,396,000 2022-11-01
Q2 2022 Reduced 1,326,066 -16,742 (-1.2%) 2.07% $639,933,000 2022-08-09
Q1 2022 Reduced 1,342,808 -13,459 (-1.0%) 1.85% $659,614,000 2022-05-10
Q4 2021 Reduced 1,356,267 -18,712 (-1.4%) 1.7% $628,684,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1746 managers reported ELEVANCE HEALTH INC FORMERLY for Q3 2026.

Managers reporting ELEVANCE HEALTH INC FORMERLY in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 19,523,886 +532,796 0.11% $7,591,277,244 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 13,823,409 -234,795 0.11% $5,374,817,887 3 qtrs
STATE STREET CORPORATION Added 10,493,831 +67,221 0.12% $4,080,211,369 44 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 8,516,420 -697,093 0.59% $3,311,354,424 48 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 6,204,274 -10,082 0.11% $2,412,345,817 3 qtrs
Sanders Capital LLC Added 5,830,605 +5,581 2.2% $2,267,055,836 48 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 5,216,506 +50,382 0.1% $2,019,246,207 48 qtrs
Invesco Ltd Added 5,068,202 +833,971 0.15% $1,970,618,428 48 qtrs
HARRIS ASSOCIATES L P Reduced 4,778,654 -145,857 2.42% $1,858,036,272 8 qtrs
First Eagle Investment Management LLC Added 4,198,657 +10,461 2.56% $1,632,521,706 48 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 12, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
0
Shared
927,194
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.